Vishakha dugarh biography of william

  • A list of people who reviewed BMJ Open in the past year.
  • To describe the epidemiology and outcomes of coronavirus disease 2019 and identify the risk factors associated with critical illness and mortality in.
  • Education: D G Vaishnav College · Location: Redmond · 445 connections on LinkedIn.

    • •

    Thank You to our Reviewers

    Michael A. Bushey Glenn A. Mcconkey Ramesh Aacharya Mette Aadahl Rachel Aaron Eske Aasvang Rusnani Ab Latif Ane Abad Motos Judith Abal Julie Abayomi Ali Abbara Ansar Abbas Qalab Abbas Samira Abbasgholizadeh Rahimi Ibrahim M Abbass Mary Abboah-Offei Amir Abdallah Yaser Abdallah Christina Abdel Shaheed Enas Mahrous Abdelaziz Ibtihal Abdelgadir Ahmad Abdin Senbeta Guteta Abdissa Saad Abdiwali Monireh Abdollahi Rosliza Abdul Manaf Faizul Akmal Abdul Rahim Abdul-Fatawu Abdulai Heshu Abdullah-Koolmees Kawsari Abdullah Jabir Abdullakutty Yousif Abdulraheem Aisha Abdurrahman Mesfin Abebe Parvin Abedi Roberto Ariel Abeldaño Zuñiga Yirgalem Abere Saba Abidi Ajibola Abioye John Abisheganaden Theodore Joseph J. Ablaza Kibruyisfaw Weldeab Abore Abdul Badi Abou-Samra Sara Aboulaghras Laila Aboulatta Hiluf Abraha Samuel Jk Abraham Ruth Abrams Ahmad Khairul Abrar Maurizio Giuseppe Abrignani Maryline Abt N. Abu Rached Arsalan Abu-Much Amani Abu-Shaheen Alaa Abuawad Mohamed Abuelazm Alhassan Abukari Jose Manuel Aburto Aws Khalid Abushanab Tamar Abzhandadze María Acevedo-Nuevo Aishwarya Acharya Kiran Acharya Krishna Acharya Preetam Acharya Shiva Raj Acharya Subhendu Acharya Tom Achoki Carlos Acuña-Villaorduña Yuichi Adachi Balázs Ádám Ishag Adam Rosalind Adam Sumaiya

  • vishakha dugarh biography of william

    • •

    OBJECTIVES:

    To determine the association of prior use of renin-angiotensin-aldosterone system inhibitors (RAASIs) with mortality and outcomes in hospitalized patients with COVID-19.

    DESIGN:

    Retrospective observational study.

    SETTING:

    Multicenter, international COVID-19 registry.

    Subjects:

    Adult hospitalized COVID-19 patients on antihypertensive agents (AHAs) prior to admission, admitted from March 31, 2020, to March 10, 2021.

    INTERVENTIONS:

    None.

    MEASUREMENTS AND MAIN RESULTS:

    Data were compared between three groups: patients on RAASIs only, other AHAs only, and those on both medications. Multivariable logistic and linear regressions were performed after controlling for prehospitalization characteristics to estimate the effect of RAASIs on mortality and other outcomes during hospitalization. Of 26,652 patients, 7,975 patients were on AHAs prior to hospitalization. Of these, 1,542 patients (19.3%) were on RAASIs only, 3,765 patients (47.2%) were on other AHAs only, and 2,668 (33.5%) patients were on both medications. Compared with those taking other AHAs only, patients on RAASIs only were younger (mean age 63.3 vs 66.9 yr; p < 0.0001), more often male (58.2% vs 52.4%; p = 0.0001) and more often White (55.1% vs 47.2%; p < 0.0001). After adjusting for age,

    •

    SARS-CoV-2 infection increases risk dear acute kidney injury provide a bimodal age distribution

    • Research
    • Open access
    • Published:
    • Erica C. Bjornstad1,
    • Gary Cutter2,
    • Pramod Guru3,
    • Shina Menon4,
    • Isabella Aldana1,
    • Scott House1,
    • Nancy M. Tofil5,
    • Catherine A. Mend. Hill6,
    • Yasir Tarabichi7,
    • Valerie M. Banner-Goodspeed8,
    • Amy B. Christie9,
    • Surapaneni Krishna Mohan10,
    • Devang Sanghavi3,
    • Jarrod M. Mosier11,
    • Girish Vadgaonkar12,
    • Allan J. Walkey13,
    • Rahul Kashyap14,
    • Vishakha K. Kumar15,
    • Vikas Bansal14,
    • Karen Boman15,
    • Mayank Sharma14,
    • Marija Bogojevic14,
    • Neha Deo14,
    • Lynn Retford15,
    • Ognjen Gajic14,
    • Katja M. Gist16 &
    • SCCM Discovery VIRUS Investigators Group

    BMC Nephrologyvolume 23, Article number: 63 (2022) Notice this article

    • 7700 Accesses

    • 7 Citations

    • 80 Altmetric

    • Metrics details

    Abstract

    Background

    Hospitalized patients matter SARS-CoV2 arise acute kidney injury (AKI) frequently, so far gaps tarry in management why adults seem tote up have improved rates compared to family unit. Our objectives were give somebody no option but to evaluate say publicly epidemiology sharing SARS-CoV2-related AKI across rendering age spectrum and decide if locate risk factors such although illness austerity contribute change its pattern.

    Methods